Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Transitional Cell

Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.

417 public trials 125 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Transitional Cell trial results

Recruiting

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

NCT06524544

Conditions
Carcinoma, Carcinoma, Transitional Cell, Locally Advanced Urothelial Carcinoma, +5 more
Locations
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • UF Health Cancer Institute - Gainesville Gainesville, Florida, United States
View all 159 locations
View Trial Details
Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

NCT03866382

Conditions
Adenocarcinoma, Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma, +71 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 582 locations
View Trial Details
Recruiting

A Study of HLX18 vs. OPDIVO® in Multiple Resected Solid Tumors

NCT07518043

Conditions
Carcinoma, Carcinoma, Transitional Cell, Esophageal and/or Cardia Cancer, +14 more
Locations
  • Fujian Medical University Union Hospital Fuzhou, China
  • The First Affiliated Hospital Zhejiang University School Of Medicine Hangzhou, China
  • The First Affiliated Hospital of Henan University of Science & Technology Luoyang, China
  • The Second Hospital of Tianjin Medical University Tianjin, China
View Trial Details
Recruiting

DBC-664 in Adult Patients With Solid Tumors

NCT07705035

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +14 more
Locations
  • START Midwest Grand Rapids, Michigan, United States
  • START New Jersey East Brunswick, New Jersey, United States
  • START New York Lake Success, New York, United States
View Trial Details
Recruiting

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

NCT07277413

Conditions
Adenocarcinoma Of Esophagus, Adenocarcinoma of Esophagus, Adenoma, +55 more
Locations
  • Providence Medical Foundation Santa Rosa, California, United States
  • Johns Hopkins Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • BRCR Global-Coral Springs Coral Springs, Florida, United States
  • Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
View all 16 locations
View Trial Details
Recruiting

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

NCT04879329

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Banner Gateway Medical Center Gilbert, Arizona, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Kaiser Permanente Anaheim Kraemer Medical Offices Anaheim, California, United States
  • Foothill Cardioology Arcadia, California, United States
View all 221 locations
View Trial Details
Recruiting

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

NCT07720284

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Research Site Hot Springs, Arkansas, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site Little Rock, Arkansas, United States
  • Research Site San Francisco, California, United States
View all 160 locations
View Trial Details
Recruiting

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

NCT07090499

Conditions
Adenocarcinoma, Adenocarcinoma Of Esophagus, Adenocarcinoma of Lung, +50 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • City of Hope at Irvine Lennar Irvine, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • UCLA Department of Medicine-Hematology/Oncology Los Angeles, California, United States
View all 30 locations
View Trial Details

Related conditions